Investors Results

What unites a global investment and research firm? Connections to our clients, our culture, one another and the communities we serve. This cohesiveness fosters

Important scientific discoveries are translating into major clinical breakthroughs, enabled by the advent of novel therapeutic modalities such as genetic

Declaration creates value in private investments through deep sector expertise, differentiated access, and authentic partnership born from a family office

Category-defining products & services are disruptive in the most elemental sense: creating new markets, changing consumer behaviors, realigning established

Our model combines a high-powered, engaged network of investors, a commitment to learning, and added fuel of fund capital to create a system for growing great

We invest venture capital in companies that dominate a niche market. A niche market is a sector of our economy, perhaps only $500 million to $1 billion

MEC is an early-stage life science venture fund that combines accomplished investment professionals and operators with a proprietary national medical network

Mid Atlantic Bio Angels group (MABA), is an angel investor group focused exclusively on new and emerging life science companies.  Membership in MABA

We source and invest in the best founders from our communities who are building the future through software and tech-enabled products. We are industry agnostic

OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. We

Health matters to absolutely everyone on the planet. No single company can advance it alone. That’s why we’re launching dozens of companies in

Founded in 2018, Rhythm VC is a NYC-based venture capital firm focused on early-stage companies taking transformational approaches to address significant

We invest and partner with early-stage companies taking transformational approaches to address significant unmet needs in healthcare.

The Riverside Company is a global investment firm focused on being one of the leading private capital options for business owners and employees at the smaller

Since 2013, Subversive Capital has been a pioneering investor in emerging industries, including: Successful early-stage investments in disruptive emerging

White Star Capital is a global multi-stage investment platform built by a team of founders, investors and operators with a track record of entering new markets,